| Investor Type | Firm |
| Type of Fund | Venture Capital Fund |
| Industries | BioTech • Businesses Solutions • Hardware (& Manufacturing) • CleanTech • HealthTech (& Fitness) • Cannabis • Blockchain (& Cryptos) • Food & Beverage • Impact • Medical Devices (& Hospital Services) • Robotics • Healthcare (& Wellness) • Life Science • Consumer • Pharmaceutical (& Medicine) • Woman Focused • Industrials • 3D Printing • Diagnostics |
| Stages | Seed, Series A, Series B, Pre-seed |
| Investing | United States • United Kingdom • France • Sweden |
| Investment Range | $2,000 - $5,000,000 |
| Investment Sweet Spot | $4,000 |
| Assets Under Management | $26,500,000 |
Genoa Ventures is a venture capital firm with a clear focus on the intersection of biology and technology. They are based in San Francisco, California, and dedicate their resources to accelerating innovation and transforming industries through strategic investments.
With a minimum investment threshold of $250,000 and a maximum investment cap of $10,000,000, their sweet spot for funding typically lies around $2,000,000. Their investment specialties include Seed, Series A, Series B, and Pre-seed funding stages, demonstrating their commitment to supporting companies from their inception through their early growth phases. Genoa Ventures operates with $26,500,000 in assets under management and has an investment thesis that revolves around the convergence of biology and technology to create significant advancements across various sectors.
They actively invest in BioTech, HealthTech (and Fitness), Blockchain (and Cryptos), Food & Beverage, Impact, Medical Devices (and Hospital Services), Robotics, Healthcare (and Wellness), Consumer, Pharmaceutical (and Medicine), and Woman Focused industries.
They recognize the vast potential that lies in the fusion of scientific innovation and technological breakthroughs, and their goal is to empower the next generation of category-defying companies that aim to build a healthier, cleaner, and more productive world. Genoa Ventures leverages scientific excellence to inform investment decisions, ensuring deep domain expertise guides their support for portfolio companies.
We are an early stage life sciences venture capital fund investing at the convergence of biology and technology.
What we look for: We invest in life sciences research tools, diagnostics, synthetic biology, industrial biotech, consumer bio and non-invasive medical devices
How we help: Our team brings diverse experience ranging from investing to operating, researching and discovering, and launching and scaling across the biology and technology sectors. Each one of us brings a unique perspective and skill set to our team so that together we can help our companies accelerate their growth, navigate around obstacles, and reach their ultimate destination.



